Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H42N.C7H7O3S |
Molecular Weight | 455.737 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)S([O-])(=O)=O.CCCCCCCCCCCCCCCC[N+](C)(C)C
InChI
InChIKey=MZMRZONIDDFOGF-UHFFFAOYSA-M
InChI=1S/C19H42N.C7H8O3S/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4;1-6-2-4-7(5-3-6)11(8,9)10/h5-19H2,1-4H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
DescriptionCurator's Comment: Description was created based on several sources, including http://www.americanpharmaceuticalreview.com/Featured-Articles/38886-Antimicrobial-Preservatives-Part-One-Choosing-a-Preservative-System/ | https://books.google.ru/books?id=EMrSBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pubmed/9880479 | http://www.medindia.net/doctors/drug_information/cetrimide.htm
Curator's Comment: Description was created based on several sources, including http://www.americanpharmaceuticalreview.com/Featured-Articles/38886-Antimicrobial-Preservatives-Part-One-Choosing-a-Preservative-System/ | https://books.google.ru/books?id=EMrSBwAAQBAJ&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.ncbi.nlm.nih.gov/pubmed/9880479 | http://www.medindia.net/doctors/drug_information/cetrimide.htm
Cetrimide is a quaternary ammonium compound. Cetrimide was first introduced as a combined cleanser and skin antiseptic by Barnes (1942). Cetrimide combines excellent detergent properties and minimal toxicity with a useful antiseptic action. Cetrimide affects membrane permeability allowing ‘leaking’ of essential cell constituents leading to cell death. This medication is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants.
Originator
Sources: http://savlonbangladesh.com/about-us/
Curator's Comment: Cetrimide was first introduced as a combined cleanser and skin antiseptic by Barnes (1942). http://www.sciencedirect.com/science/article/pii/S0140673600701000 reference retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18132350
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0002194 Sources: https://www.ncbi.nlm.nih.gov/pubmed/31262888 |
|||
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | CETRIMIDE Approved UseCetrimide is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants. |
|||
Primary | CETRIMIDE Approved UseCetrimide is a skin antiseptic and disinfectant prescribed for seborrhoeic dermatitis and wound cleansing. The cream has a bactericidal activity against gram-positive bacteria and incompatible with soaps and other anionic surfactants. |
Sample Use Guides
Wound cleansing - Topical : Adult: Apply 0.1-1% aqueous solution or 0.5% cream onto affected area.
Seborrhoeic dermatitis - Topical : Adult: Apply 10% shampoo solution onto the scalp.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13990631
Cetrimide, at 30 ug/ml inhibited growth of Aspergillus niger.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB61495
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
SUB60057
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
DTXSID50883325
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
100000134328
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
C020810
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
9868636
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
205-324-8
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
SUB59820
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
1P489GK6AR
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
138-32-9
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | |||
|
m3294
Created by
admin on Fri Dec 15 19:47:46 GMT 2023 , Edited by admin on Fri Dec 15 19:47:46 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY
SUBSTANCE RECORD